Over the past 9 months, 4 senators led by Sen. Dick Durbin (D-In poor health.) have performed an inquiry into the rising partnerships between direct-to-consumer telehealth firms and pharmaceutical producers. Within the final two years, each Pfizer and Eli Lilly launched web sites that, amongst different issues, join sufferers with a telehealth supplier for circumstances their drugs deal with.
The chance to “discuss to a physician now” will increase entry to care, the drug firms say. However the legislators, and a few well being coverage watchers, fear that relationships between pharma and telehealth firms might drive sufferers towards costly and pointless drugs.
Right this moment, the senators launched new particulars of these enterprise preparations, knowledgeable by the businesses’ responses to their probes.
This text is unique to STAT+ subscribers
Unlock this text — plus each day protection and evaluation of the pharma trade — by subscribing to STAT+.
Have already got an account? Log in
To learn the remainder of this story subscribe to STAT+.
